US FDA pilot aims for 30-day review of 510(k)s submissions for IVDs, radiology devices
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration has launched a six-month pilot programme under which it will aim to issue decisions on certain "good quality" pre-market notification (510(k)) submissions within 30 days, rather than its current standard of 90 days1.
You may also be interested in...
'Quik' Review Program Builds On US FDA eSubmission Efforts
The agency says 510(k)s submitted via an electronic template for any of about 40 product types might get a speedier review under a new pilot program.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency
The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.